跳至主要内容
临床试验/NCT03291366
NCT03291366Unknown1 期

Intrathecal Injection of Mesenchymal Stem Cells in Central Nervous System injury2017

Fuzhou General Hospital0 个研究点目标入组 30 人开始时间: 2017年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
30
主要终点
life quality score

研究概览

简要总结

Central nervous system (CNS) injury leads to morbidity in patients, which has few good rehabilitation measures. Mesenchymal stem cells seem to have regenerative and tissue-repairing capabilities. The investigators design this study to infuse mesenchymal stem cells (MSCs) intrathecally to CNS injury patients, and observe the safety and efficacy by recording the change of nervous system scores, trying to prove the effect of MSC in rehabilitate CNS injury.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CNS injury > 3 months
  • age > 18 years
  • willing to give consent
  • stable vital signs
  • absence of active infectcion

排除标准

  • any contradiction to intrathecal infusion
  • age < 18 years
  • CNS injury < 3 months
  • CNS injury > 3 years

研究组 & 干预措施

MSC

Experimental

infusion of aUCMSC and conventional therapy

干预措施: conventional treatment (Drug)

MSC

Experimental

infusion of aUCMSC and conventional therapy

干预措施: UCMSCC (Drug)

conventional

Active Comparator

conventional therapy

干预措施: conventional treatment (Drug)

结局指标

主要结局

life quality score

时间窗: 1y

次要结局

  • adverse events(1y)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jianming Tan

Professor

Fuzhou General Hospital

相似试验